ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Roche’s SMA drug gets PRIME regulatory status in Europe
pharmaphorum
December 19, 2018Roche is hoping to challenge Biogen with a new treatment for the rare muscle wasting disease spinal muscular atrophy – and the plans just got a boost after European regulators gave it special priority.
Pharma Sources Insight January 2025
